The ELISA human osteoprotegrin test (TNFRSF11B) (human OPG) quantifies human OPG in serum, plasma, cell culture supernatants or other human body fluids. The dosage will recognize exclusively human OPG...
The ELISA human osteoprotegrin test (TNFRSF11B) (human OPG) quantifies human OPG in serum, plasma, cell culture supernatants or other human body fluids. The dosage will recognize only natural and recombinant human OPG. The principle of the solid-phase L-ELISA sandwich method for human OPG (an immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-assembled in the wells of the supplied microplate. Samples or controls are then added to these wells and bind to the immobilized antibody (capture). The sandwich is formed by binding the second antibody (detector) to the target on an epitope different from the capture antibody. An antibody conjugated with the enzyme binds the formed sandwich. After incubation and washing steps to remove the microplate from unbound substances, a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
Act as a decoy receptor for TNFSF11/RANKL and thus neutralize its function in the osteoclastogenesis. Prevents osteoclast activation and promotes osteoclast apoptosis in vitro. Bone homeostasis appears to depend on the local ratio of TNFSF11 to TNFRSF11B. May also play a role in preventing blood calcification. May act as a decoy receptor for TNFSF10/TRAIL and protect against apoptosis. TNFSF10/TRAIL bond blocks inhibition of osteoclastogenesis.
Sensitivity
Sensitivity of the dosage: 2.5 pg/ml.
Measurement range
Dose range: 15.6-1.000 pg/ml.
Duration of dosing
Total duration of dosing: 3 h 10 min.
Reproducibility
Coefficient of intra-dose variation 7%, inter-dose 8%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15581507 |
| Specifications |
| Accession number | O00300 |
| Dose range | 15.6-1.000 pg/ml |
| Sensitivity of the dosage | 2.5 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Supernatant |
| Target species | Human |
| For use with (application) | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 4982 |
| Gene symbol(s) | OCIF,OPG,PDB5,TR1 |
| Coefficient of inter-dose variation | 8% |
| Coefficient of intra-dose variation | 7% |
| Contents of kits | Microplate with 96 pre-coated wells, Biotinylated detection antibody, Sample diluent, Sample diluent, lyophilized, Wash buffer concentrate, Wash buffer concentrate, Substrate solution, 10x lysis pad, Adhesive plate covers, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 128 Tests |
| Regulatory status | RUO |
| Synonym | Osteoprotegerin, member 11b of the TNF-R superfamily |
| Target | Human |
| Test time | 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; Serum, 50 μl; Supernatant, 50 μl |
| Storage and shipping |
| Storage conditions | -20°C |
| Total duration of dosing | 3 h 10 min |
Origin and customs
| Manufacturer ref. | BMS2021INST |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.